Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CFO Sells 25,118 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CFO Alexis Desieno sold 25,118 shares of Cardlytics stock in a transaction that occurred on Friday, November 15th. The stock was sold at an average price of $3.43, for a total value of $86,154.74. Following the completion of the transaction, the chief financial officer now directly owns 116,481 shares in the company, valued at approximately $399,529.83. This represents a 17.74 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Alexis Desieno also recently made the following trade(s):

  • On Wednesday, October 2nd, Alexis Desieno sold 7,487 shares of Cardlytics stock. The stock was sold at an average price of $3.08, for a total value of $23,059.96.

Cardlytics Price Performance

Shares of NASDAQ:CDLX opened at $3.38 on Friday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The stock has a market cap of $171.77 million, a PE ratio of -0.55 and a beta of 1.61. The stock’s fifty day simple moving average is $3.72 and its two-hundred day simple moving average is $6.37. Cardlytics, Inc. has a 1-year low of $2.89 and a 1-year high of $20.52.

Cardlytics (NASDAQ:CDLXGet Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.18. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. The company had revenue of $67.06 million for the quarter, compared to analyst estimates of $57.77 million. During the same period last year, the firm earned ($0.26) earnings per share. The firm’s revenue was down 15.1% on a year-over-year basis. As a group, analysts forecast that Cardlytics, Inc. will post -1.72 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently issued reports on CDLX shares. Evercore ISI began coverage on shares of Cardlytics in a research report on Friday, October 11th. They set an “in-line” rating and a $4.00 target price on the stock. Lake Street Capital lowered shares of Cardlytics from a “buy” rating to a “hold” rating and dropped their price objective for the company from $18.00 to $5.00 in a report on Thursday, August 8th. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Northland Capmk lowered Cardlytics from a “strong-buy” rating to a “hold” rating in a research report on Friday, August 16th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a research note on Thursday, November 7th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $6.92.

Check Out Our Latest Analysis on Cardlytics

Hedge Funds Weigh In On Cardlytics

Several hedge funds have recently modified their holdings of the company. Atom Investors LP bought a new position in shares of Cardlytics in the third quarter valued at approximately $33,000. Canton Hathaway LLC grew its stake in Cardlytics by 95.7% in the 2nd quarter. Canton Hathaway LLC now owns 4,500 shares of the company’s stock valued at $37,000 after purchasing an additional 2,200 shares during the period. SG Americas Securities LLC bought a new position in Cardlytics in the 3rd quarter valued at $45,000. Intech Investment Management LLC purchased a new stake in shares of Cardlytics during the 3rd quarter valued at $47,000. Finally, Quadrature Capital Ltd bought a new stake in shares of Cardlytics during the 3rd quarter worth $63,000. Institutional investors own 68.10% of the company’s stock.

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Stories

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.